Bionano Genomics, Inc. (BNGO) Q4 2024 Annual Earnings
BNGO·Reported March 31, 2025·After market close
Bionano Genomics, Inc. reported Q4 2024 revenue of $8.2M, beat analyst consensus of $6.2M by $2.0M. Diluted EPS came in at $-57.49, missed the $-6.00 consensus by $51.49.
Revenue
$8.2Mbeat by $2.0M
Consensus: $6.2MDiluted EPS
$-57.49missed by $51.49
Consensus: $-6.00
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Bionano Genomics, Inc.'s Q4 2024 earnings report.
Bionano Genomics, Inc. (BNGO) reported Q4 2024 earnings on March 31, 2025 after market close.
Bionano Genomics, Inc. reported revenue of $8.2M and diluted EPS of $-57.49 for Q4 2024.
Revenue beat the consensus estimate of $6.2M by $2.0M. EPS missed the consensus estimate of $-6.00 by $51.49.
You can read the 10-K periodic report (0001411690-25-000037) directly on SEC EDGAR. The filing index links above go to sec.gov.